Literature DB >> 23073702

ISCEV standard for clinical pattern electroretinography (PERG): 2012 update.

Michael Bach1, Mitchell G Brigell, Marko Hawlina, Graham E Holder, Mary A Johnson, Daphne L McCulloch, Thomas Meigen, Suresh Viswanathan.   

Abstract

The pattern electroretinogram (PERG) is a retinal response evoked by a contrast-reversing pattern, usually a black and white checkerboard, which provides information about macular and retinal ganglion cell function. This document from the International Society for Clinical Electrophysiology of Vision (www.iscev.org) is a scheduled revision of the ISCEV PERG Standard, which updates and replaces the 2007 update and all earlier versions. The standard defines a single minimum stimulus and recording protocol for clinical PERG testing to assist practitioners in obtaining good quality responses and to facilitate inter-laboratory comparison. The present revision tightens stimulus specifications, expands on steady-state PERG recording, addresses visual stimulus display distinctions (CRT vs. LCD), and provides a more explicit definition of response components.

Mesh:

Year:  2012        PMID: 23073702     DOI: 10.1007/s10633-012-9353-y

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  8 in total

1.  Standard for pattern electroretinography. International Society for Clinical Electrophysiology of Vision.

Authors:  M Bach; M Hawlina; G E Holder; M F Marmor; T Meigen; Y Miyake
Journal:  Doc Ophthalmol       Date:  2000-07       Impact factor: 2.379

2.  Guidelines for calibration of stimulus and recording parameters used in clinical electrophysiology of vision.

Authors:  Mitchell Brigell; Michael Bach; Colin Barber; Anne Moskowitz; John Robson
Journal:  Doc Ophthalmol       Date:  2003-09       Impact factor: 2.379

3.  ISCEV Standard for full-field clinical electroretinography (2008 update).

Authors:  M F Marmor; A B Fulton; G E Holder; Y Miyake; M Brigell; M Bach
Journal:  Doc Ophthalmol       Date:  2008-11-22       Impact factor: 2.379

4.  ISCEV standard for clinical visual evoked potentials (2009 update).

Authors:  J Vernon Odom; Michael Bach; Mitchell Brigell; Graham E Holder; Daphne L McCulloch; Alma Patrizia Tormene
Journal:  Doc Ophthalmol       Date:  2009-10-14       Impact factor: 2.379

5.  ISCEV standard for clinical electro-oculography (2010 update).

Authors:  Michael F Marmor; Mitchell G Brigell; Daphne L McCulloch; Carol A Westall; Michael Bach
Journal:  Doc Ophthalmol       Date:  2011-02-05       Impact factor: 2.379

Review 6.  ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition).

Authors:  Donald C Hood; Michael Bach; Mitchell Brigell; David Keating; Mineo Kondo; Jonathan S Lyons; Michael F Marmor; Daphne L McCulloch; Anja M Palmowski-Wolfe
Journal:  Doc Ophthalmol       Date:  2011-10-30       Impact factor: 2.379

7.  ISCEV standard for clinical pattern electroretinography--2007 update.

Authors:  Graham E Holder; Mitchell G Brigell; Marko Hawlina; Thomas Meigen; Michael Bach
Journal:  Doc Ophthalmol       Date:  2007-04-14       Impact factor: 2.379

  8 in total
  159 in total

1.  ABCA4 gene screening by next-generation sequencing in a British cohort.

Authors:  Kaoru Fujinami; Jana Zernant; Ravinder K Chana; Genevieve A Wright; Kazushige Tsunoda; Yoko Ozawa; Kazuo Tsubota; Andrew R Webster; Anthony T Moore; Rando Allikmets; Michel Michaelides
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-11       Impact factor: 4.799

2.  Electoretinographic evidence of retinal ganglion cell-dependent function in schizophrenia.

Authors:  Pantea Moghimi; Nathalia Torres Jimenez; Linda K McLoon; Theoden I Netoff; Michael S Lee; Angus MacDonald; Robert F Miller
Journal:  Schizophr Res       Date:  2019-10-12       Impact factor: 4.939

3.  Pattern electroretinogram to detect glaucoma: comparing the PERGLA and the PERG Ratio protocols.

Authors:  Michael Bach; Anke Ramharter-Sereinig
Journal:  Doc Ophthalmol       Date:  2013-10-15       Impact factor: 2.379

4.  Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma.

Authors:  Vincenzo Parisi; Marco Centofanti; Lucia Ziccardi; Lucia Tanga; Manuele Michelessi; Gloria Roberti; Gianluca Manni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-26       Impact factor: 3.117

5.  Spatial differences in corneal electroretinogram potentials measured in rat with a contact lens electrode array.

Authors:  Yelena Krakova; Hadi Tajalli; Sanitta Thongpang; Zahra Derafshi; Tamas Ban; Safa Rahmani; Ashley N Selner; Amani Al-Tarouti; Justin C Williams; John R Hetling
Journal:  Doc Ophthalmol       Date:  2014-09-30       Impact factor: 2.379

6.  Relationship between transient and steady-state pattern electroretinograms: theoretical and experimental assessment.

Authors:  Özcan Özdamar; Jonathon Toft-Nielsen; Jorge Bohórquez; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-04       Impact factor: 4.799

Review 7.  [Electrophysiology in ophthalmology].

Authors:  T Meigen
Journal:  Ophthalmologe       Date:  2015-06       Impact factor: 1.059

8.  The pattern ERG in chicks - Stimulus dependence and optic nerve section.

Authors:  Lisa A Ostrin; Vivian Choh; Christine F Wildsoet
Journal:  Vision Res       Date:  2016-09-29       Impact factor: 1.886

9.  Comparison of human expert and computer-automated systems using magnitude-squared coherence (MSC) and bootstrap distribution statistics for the interpretation of pattern electroretinograms (PERGs) in infants with optic nerve hypoplasia (ONH).

Authors:  Anthony C Fisher; Daphne L McCulloch; Mark S Borchert; Pamela Garcia-Filion; Cassandra Fink; Antonio Eleuteri; David M Simpson
Journal:  Doc Ophthalmol       Date:  2015-03-12       Impact factor: 2.379

10.  Ganglion cell loss in early glaucoma, as assessed by photopic negative response, pattern electroretinogram, and spectral-domain optical coherence tomography.

Authors:  Barbara Cvenkel; Maja Sustar; Darko Perovšek
Journal:  Doc Ophthalmol       Date:  2017-05-31       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.